Today: 12 April 2026
Carvana stock ticks up near $470 as Wall Street waits on CPI and rate signals
12 January 2026
1 min read

Carvana stock ticks up near $470 as Wall Street waits on CPI and rate signals

New York, January 12, 2026, 13:30 EST — The regular session is underway.

  • Carvana shares climbed roughly 1.6% by midday, beating a largely steady U.S. market.
  • The stock remains close to its recent highs, with valuation and funding costs continuing to draw attention.
  • Investors are focused on Tuesday’s U.S. CPI report and the upcoming earnings schedule for the company.

Carvana Co. shares rose Monday, extending a strong start to the year that has kept the online used-car retailer close to its recent peaks. The stock gained 1.6%, settling at $470.52 after swinging between $455.32 and $470.92 during the session.

The gain arrived after the broader market steadied following an early stumble sparked by renewed doubts about the Federal Reserve’s independence. Traders are now bracing for Tuesday’s U.S. consumer price index report, looking for clues on the next move in rates.

Carvana’s current status as a growth stock means its price is highly sensitive to changes in rate expectations. When borrowing costs rise, car buyers often pull back, putting pressure on the lofty valuations that investors have been assigning to fast-growing companies.

No company announcement came alongside Monday’s price action. In used cars, CarMax shares barely moved, and ACV Auctions edged up modestly, showing no obvious momentum across the sector.

Carvana stands out as one of the market’s sharpest turnarounds. It joined the S&P 500 in late December following a strong rebound from its 2022 lows. Reuters pointed out earlier that the stock was still priced at a hefty forward earnings multiple compared to traditional automakers.

But the rapid rise in the stock also brings risk. With such lofty expectations, there’s hardly any margin for error—be it weaker demand, tighter lending conditions, or a tougher interest rate environment squeezing buyers who rely on financing.

Investors are zeroing in on the upcoming results for clear indicators: unit sales, profit per vehicle, and adjusted EBITDA — a cash-earnings metric that excludes interest, taxes, and depreciation.

Tuesday’s CPI report (Jan. 13) stands as the next major macro event. A stronger-than-expected reading could reignite concerns about interest rates, pressuring rate-sensitive, high-multiple stocks.

Carvana’s next major event is its earnings release. While the company hasn’t officially set a date, market watchers expect it around mid-February—likely Feb. 18—following its usual schedule.

Stock Market Today

  • Tel Aviv Stock Exchange hits record highs as Iran ceasefire boosts market
    April 12, 2026, 4:11 AM EDT. The Tel Aviv Stock Exchange surged to all-time highs on Friday, with the TA-35 and TA-125 indices climbing 1.9% to 4,443.22 and 4,335.72, respectively. The TA-90 rose 1.6%. Gains were led by the insurance index, up 6%, banks (3.2%), and real estate (2.7%). However, defense stocks fell, dragging the TA Defense Index down 2.7%, amid declines in Elbit Systems and Next Vision Stabilized Systems. The dollar weakened to roughly 3.03 shekels, its lowest since 1995, reflecting reduced demand for U.S. currency. The Bank of Israel set its representative rates lower for both the dollar and euro, signaling easing currency pressure. Market optimism follows news of an Iran ceasefire, which investors see as a positive geopolitical development.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

11 April 2026
Snowflake shares fell 8.4% to $121.11 on Friday after an 11.7% drop Thursday, as investors sold off software stocks amid concerns over new AI tools from Anthropic and OpenAI. The stock now trades just above its 52-week low. The S&P 500 Software and Services Index is down 25.5% for the year. Snowflake reported fourth-quarter product revenue of $1.23 billion, up 30% from a year earlier.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 11:59 PM EDT DocuSign Stock Review: Is the 42% Yearly Drop a Buying Opportunity? April 11, 2026, 11:59 PM EDT. DocuSign (DOCU) shares have fallen 42.3% over the past year, raising questions about their value. Despite recent weakness, a Discounted Cash Flow (DCF) analysis suggests the stock is 68.1% undervalued, with estimated intrinsic value around $134.42 versus a current price near $42.89. The DCF model projects growing free cash flows from $990 million in 2026 to $1.37 billion by 2029. Investors remain cautious amid evolving software spending trends
AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy
Previous Story

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

XPeng (XPEV) stock jumps 8% as flying-car IPO report hits tape, EU tariff rules in focus
Next Story

XPeng (XPEV) stock jumps 8% as flying-car IPO report hits tape, EU tariff rules in focus

Go toTop